Precursor Cell Lymphoblastic Leukemia-Lymphoma
-
Subject Areas on Research
-
A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.
-
A case of infantile acute lymphoblastic leukemia presenting with rearrangement of MLL at 11q23 and apparent insertion or translocation at 10p12.
-
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
-
A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.
-
A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children.
-
A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis.
-
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.
-
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.
-
A substrate specific functional polymorphism of human gamma-glutamyl hydrolase alters catalytic activity and methotrexate polyglutamate accumulation in acute lymphoblastic leukaemia cells.
-
AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and Survival.
-
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.
-
Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia.
-
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
-
Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
-
Acute leukemia in children.
-
Acute lymphoblastic leukaemia in childhood: cell proliferation without rest.
-
Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I.
-
Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
-
Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia.
-
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia.
-
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission.
-
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
-
An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a Quality Assurance Review Center-Pediatric Oncology Group study.
-
An exploratory study of environmental and medical factors potentially related to childhood cancer.
-
An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia.
-
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.
-
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.
-
Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease?
-
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
-
Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
-
Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia.
-
Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia.
-
B-lymphoblastic leukemia in a patient with chronic lymphocytic leukemia: Sequential development of biclonal B-cell neoplasms over a 23-year period in a single individual.
-
BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with childhood acute lymphoblastic leukemia.
-
Bacillary angiomatosis in a child undergoing chemotherapy.
-
Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia.
-
Bilateral optic disk edema and blindness as initial presentation of acute lymphocytic leukemia.
-
Biomarker clustering to address correlations in proteomic data.
-
Blinatumomab: A New Treatment for Adults With Relapsed Acute Lymphocytic Leukemia.
-
Bone marrow transplantation from histocompatible sibling donors for patients with acute lymphoblastic leukemia.
-
CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells.
-
Carcinogenicity of inhaled benzene in CBA mice.
-
Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia.
-
Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation.
-
Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.
-
Cerebrospinal fluid protein elevation secondary to a subdural fluid collection in a child receiving multiple lumbar punctures.
-
Cerebrospinal fluid proteomics in children during induction for acute lymphoblastic leukemia: A pilot study.
-
Changes in Oxidant Defense, Apoptosis, and Cognitive Abilities During Treatment for Childhood Leukemia.
-
Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.
-
Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.
-
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.
-
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
-
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
-
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
-
Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia.
-
Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers.
-
Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
-
Comparative pharmacokinetic studies of three asparaginase preparations.
-
Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
-
Comparison of fluorescence in situ hybridization, cytogenetic analysis, and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a Pediatric Oncology Group study.
-
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B.
-
Computerized cognitive training in survivors of childhood cancer: a pilot study.
-
Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia.
-
Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia.
-
DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study.
-
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.
-
Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease.
-
Deficient innate immunity, thymopoiesis, and gene expression response to radiation in survivors of childhood acute lymphoblastic leukemia.
-
Diet, physical activity, and body composition changes during the first year of treatment for childhood acute leukemia and lymphoma.
-
Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature.
-
Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.
-
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.
-
Early integration of palliative care into the care of patients with cancer.
-
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
-
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511.
-
Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation.
-
Epigenetic regulation of human gamma-glutamyl hydrolase activity in acute lymphoblastic leukemia cells.
-
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.
-
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
-
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis.
-
Evaluation of Biomarkers of Oxidative Stress and Apoptosis in Patients With Severe Methotrexate Neurotoxicity: A Case Series.
-
F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.
-
Factor analysis and validity of the Conners Parent and Teacher Rating Scales in childhood cancer survivors.
-
Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.
-
Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
-
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
-
Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.
-
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission.
-
GATA3 risk alleles are associated with ancestral components in Hispanic children with ALL.
-
GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21.
-
Gene therapy for SCID--a complication after remarkable progress.
-
Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
-
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.
-
Genome-wide study of methotrexate clearance replicates SLCO1B1.
-
Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia.
-
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.
-
Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.
-
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation.
-
Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.
-
Hematolymphoid malignancies with intraocular intravascular involvement: report of 2 cases.
-
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
-
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).
-
Identification and assessment of prognostic factors.
-
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.
-
Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia.
-
In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia.
-
In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase.
-
Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia.
-
Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia.
-
Influence of Nitrosative Stress on Fatigue During Childhood Leukemia Treatment.
-
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program.
-
Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling.
-
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program.
-
Initial testing of JNJ-26854165 (Serdemetan) by the pediatric preclinical testing program.
-
Initial testing of cisplatin by the pediatric preclinical testing program.
-
Initial testing of dasatinib by the pediatric preclinical testing program.
-
Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP).
-
Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program.
-
Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia.
-
Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.
-
Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group.
-
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
-
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.
-
Is it time to expand the use of cord blood donor transplantation in relapsed ALL?
-
Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study.
-
Leukaemia hijacks a neural mechanism to invade the central nervous system.
-
Liver transplantation in an adolescent with acute liver failure from acute lymphoblastic leukemia.
-
Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors.
-
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
-
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).
-
Longitudinal assessment of nutritional status in children treated for acute lymphoblastic leukaemia in Cuba.
-
Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
-
Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.
-
Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update).
-
Lymphoblastic lymphoma and excessive toxicity from chemotherapy: an unusual presentation for Fanconi anemia.
-
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia.
-
Management of leukemic hyperleukocytosis with hydration, urinary alkalinization, and allopurinol. Are cranial irradiation and invasive cytoreduction necessary?
-
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
-
Mathematics intervention for prevention of neurocognitive deficits in childhood leukemia.
-
More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.
-
Mucormycosis Rhinosinusitis at Diagnosis of Acute Lymphoblastic Leukemia: Diagnostics and Management Challenges in a Low-Middle-income Country.
-
Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia.
-
NCCN task force report: molecular markers in leukemias and lymphomas.
-
Necrotizing myofasciitis: an atypical cause of "acute abdomen" in an immunocompromised child.
-
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
-
Neurocognitive Predictors of Academic Outcomes Among Childhood Leukemia Survivors.
-
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
-
Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
-
Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
-
Obesity in pediatric oncology.
-
Ordinary Differential Equation Models for Adoptive Immunotherapy.
-
Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
-
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
-
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.
-
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.
-
Oxidative Stress, Motor Abilities, and Behavioral Adjustment in Children Treated for Acute Lymphoblastic Leukemia.
-
Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia.
-
Oxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy.
-
Patient-reported symptoms and quality of life
in adults with acute leukemia: a systematic review.
-
Persistent and Prolonged Parvovirus B19 Viremia in a Pediatric Patient With Acute Lymphoblastic Leukemia.
-
Pharmacologic purging of malignant T cells from human bone marrow using 9-beta-D-arabinofuranosylguanine.
-
Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study.
-
Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study.
-
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
-
Poor Oral Health Linked with Increased Risk of Infectious Complications in Adults with Leukemia.
-
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
-
Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.
-
Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients.
-
Presentation and outcomes for children with bone marrow necrosis and acute lymphoblastic leukemia: a literature review.
-
Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.
-
Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia.
-
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.
-
Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia.
-
Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distress.
-
Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia.
-
Reduced intensity versus myeloablative allogeneic stem cell transplantation for the treatment of acute myeloid leukemia, myelodysplastic syndrome and acute lymphoid leukemia.
-
Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer.
-
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995).
-
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.
-
Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X.
-
Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
-
Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia.
-
Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
-
Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.
-
Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA.
-
Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells.
-
Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation.
-
Successful treatment of disseminated cryptococcal infection in a pediatric acute lymphoblastic leukemia patient during induction.
-
Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management.
-
Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
-
The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.
-
The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies.
-
The incidence of testicular recurrence in boys with acute leukemia treated with total body and testicular irradiation and stem cell transplantation.
-
The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
-
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
-
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.
-
The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia.
-
The use of distraction and imagery with children during painful procedures.
-
The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation.
-
Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493).
-
Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review.
-
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
-
Trajectories of Obesity and Overweight Rates Among Survivors of Childhood Acute Lymphoblastic Leukemia.
-
Treatment of adults with acute lymphoblastic leukemia: do the specifics of the regimen matter?: Results from a prospective randomized trial.
-
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.
-
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.
-
Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
-
Use of ED and hospital services for patients with acute leukemia after induction therapy: one year follow-up.
-
Validation of DNA methylation biomarkers for diagnosis of acute lymphoblastic leukemia.
-
Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
-
Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score.
-
Working memory training in survivors of pediatric cancer: a randomized pilot study.
-
Keywords of People
-
Barfield, Raymond Carlton,
Professor of Pediatrics,
Duke Science & Society
-
Buckley, Rebecca Hatcher,
James Buren Sidbury Professor of Pediatrics, in the School of Medicine,
Immunology
-
Lagoo, Anand Shreeram,
Professor of Pathology,
Pathology